The ITI Board of Directors has appointed Dr. Alexander Ochsner as CEO of the ITI. With his strong background in the sciences as well as his extensive management experience, Dr. Ochsner is the ideal choice to successfully lead the ITI’s business affairs and execute on the ITI’s objectives and strategy following the resignation of Dr. Friedrich Buck as Executive Director of the ITI earlier this year.
Dr. Ochsner is a seasoned executive with more than 15 years international experience in the field of implant dentistry. After many years in senior roles at Zimmer Dental and Nobel Biocare, he joined Straumann in 2012 as a member of the Executive Management Board. He first served as Head of Sales APAC and in recent years as Head of Global People Management & Development. He is a senior and experienced leader with strong conceptual skills as well as the ability to effectively execute on strategic plans. Dr. Ochsner has an excellent understanding of the relationship between the ITI and Straumann and is already familiar with the ITI’s recent projects and activities. He holds a PhD and MSc in natural sciences from the Swiss Federal Institute of Technology (ETH) in Zurich.
